Frequent activation of the PI3K/AKT/mTOR pathway in many cancers, including ovarian cancer, suggests the PI3K/AKT/mTOR pathway to be an attractive target for therapeutic intervention[52,69]. The gene discussed is PIK3CB; the disease is cancer.